Skip to main content
Signal8

ANAPTYSBIO, INC (ANAB)

AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States. The company’s products include Rosnilimab, a selective pathogenic T cell deplete which completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis; ANB033, a CD122 antagonist, which is in a Phase 1b trial for celiac disease and eosinophilic esophagitis; ANB101, a BDCA2 modulator antibody which is in Phase 1a trial that specifically targets plasmacytoid dendritic cells and inhibits interferon secretion and modulates antigen presentation; dostarlimab, a PD-1 antagonist for various solid tumor indications; and Imsidolimab, an antibody that inhibits the interleukin-36 receptor, which is in the Phase 3 development for the treatment of generalized pustular psoriasis. It focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has collaborations agreement with GSK and Vanda. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

AnaptysBio, Inc. logo

AnaptysBio, Inc.

NASDAQ:ANABHealthcare
+1.31%$48.73
AH Close$48.48-0.51%vs close
Mkt Cap$1.46B
Float17.63M
O/S29.9M
Inst Own101.0%
SI29.7%
Dilution
AnaptysBio, Inc. logoNASDAQ:ANAB$48.73+1.31%
Delisting Issues Timeline
Financials Summary
Revenue$234.6M
Net Income-$13.23M
Total Assets$364.39M
Free Cash Flow$19.61M
Debt & Equity
Debt 27%
Equity 73%
Total Debt$14.11M
Total Equity$37.21M
Shares Outstanding
Short Interest
Split History2 splits
  1. 1.5:1Forward split
    Apr 20, 20261 share → 1.5
  2. 1.5:1Forward split
    Apr 20, 20261 share → 1.5
Balance Sheet Details
Assets$364.39M
Liabilities$327.19M
Accounts Receivable$33.85M
Accounts Payable$3.87M
Inventory$0
PP&E (Net)$13.89M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Revenue$234.6M$91.28M$17.16M$10.29M$63.17M$75M$8M$5M$10M$16.68M$17.57M$15.84M$5.48M
YoY Growth157.0%432.0%66.8%-83.7%-15.8%837.5%60.0%-50.0%-40.1%-5.0%10.9%188.9%-
Cost of Revenue$2.42M$163.84M$132.28M$88.8M$98.5M$80.03M$99.34M$56.2M$29.44M$15.42M$17.3M$8.61M$8.82M
Gross Profit$232.18M-$72.56M-$115.13M-$78.51M-$35.32M-$5.03M-$91.34M-$51.2M-$19.44M$1.26M$267K$7.22M-$3.34M
Gross Margin99.0%-79.5%-671.0%-763.2%-55.9%-6.7%-1141.7%-1023.9%-194.4%7.6%1.5%45.6%-60.9%
Research and Development$135.97M$163.84M$139.62M$88.8M$98.5M$80.03M$99.34M$56.3M$30.94M$22.62M$17.3M$8.61M$8.82M
Selling, General, and Administrative$50.74M$42.39M$41.95M$36.64M$21.49M$18.85M$16.09M$15.53M$9.34M$4.29M$3.59M$2.35M$1.95M
Other-$2.42M-$163.84M-$132.28M-$88.8M-$98.5M-$80.03M-$99.34M-$56.3M-$30.94M-$22.62M-$17.3M-$8.61M$0
Total Operating Expenses$184.28M$42.39M$49.28M$36.64M$21.49M$18.85M$16.09M$15.53M$9.34M$4.29M$3.59M$2.35M$1.32M
Operating Income (EBIT)$47.9M-$114.95M-$164.41M-$115.15M-$56.81M-$23.88M-$107.43M-$66.72M-$28.78M-$3.02M-$3.32M$4.87M-$5.29M
Operating Margin20.4%-125.9%-958.3%-1119.4%-89.9%-31.8%-1342.9%-1334.4%-287.8%-18.1%-18.9%30.7%-96.4%
Interest Expense$79.89M$50.09M$18.08M$21.11M$1.45M$0$1.04M$1.65M$1.77M$458K$460K$1.28M$886K
Interest Income$13.5M$19.79M$18.87M$7.55M$431K$3.96M$10.98M$6.68M$1.62M$0$0$2K$1K
Other Income (Expense)-$60.96M-$30.28M$788K-$13.55M-$982K$3.95M$9.94M$4.87M-$1.29M-$1.23M-$1.94M-$1.34M-$258K
Income Before Tax (EBT)-$13.07M-$145.23M-$163.62M-$128.7M-$57.8M-$19.93M-$97.49M-$61.85M-$30.07M-$4.26M-$5.27M$3.53M-$5.54M
Income Tax Expense$164K$3K-$4K$24K$0$0-$152K-$192K$0$0$139K$0$0
Net Income-$13.23M-$145.23M-$163.62M-$128.72M-$57.8M-$19.93M-$97.34M-$61.66M-$30.07M-$4.26M-$5.41M$232K-$5.54M
Net Income Margin-5.6%-159.1%-953.7%-1251.3%-91.5%-26.6%-1216.7%-1233.1%-300.7%-25.5%-30.8%1.5%-101.1%
Supplementary Data
EPS-0.46-5.12-6.08-4.57-2.11-0.73-3.60-2.50-1.52-0.23-0.380.24-2.28
Diluted EPS-0.46-5.12-6.08-4.57-2.11-0.73-3.60-2.50-1.52-0.23-0.360.24-2.23
Weighted Average OS27.79M28.38M26.92M28.16M27.43M27.30M27.06M24.67M19.78M2.64M2.55M2.48M1.11M
EBITDA$69.25M-$92.74M-$154.7M-$105.26M-$55.71M-$19.37M-$95.93M-$59.88M-$28.11M-$3.57M-$4.53M$5.12M-$4.08M
EBITDA Margin29.5%-101.6%-901.6%-1023.2%-88.2%-25.8%-1199.2%-1197.6%-281.1%-21.4%-25.8%32.3%-74.4%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Assets
Current Assets
Cash and Cash Equivalents$238.2M$123.08M$35.97M$71.31M$495.73M$250.46M$171.02M$113.6M$81.19M$51.23M$51.68M$22.19M$2.81M
Short-Term Investments$73.44M$262.29M$354.94M$369.93M$52.37M$143.2M$203.21M$313.49M$167.22M$0$0$0$0
Cash and Short-Term Investments$311.64M$385.37M$390.9M$441.24M$548.1M$393.65M$374.23M$427.08M$248.41M$51.23M$51.68M$22.19M$2.81M
Accounts Receivable$33.85M$40.77M$6.85M$1.42M$876K$0$0$174K$1.6M$5.34M$1.23M$1.46M$0
Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Assets$4.76M$5.74M$9.08M$4.54M$0$0$0$0$0$0$554K$758K$0
Total Current Assets$350.25M$431.88M$406.83M$447.2M$553.88M$396.56M$377.73M$434.22M$252.7M$58.21M$53.46M$24.4M$3.05M
Long-Term Assets
Property, Plant & Equipment Net$13.89M$16.23M$18.27M$19.99M$21.84M$2.13M$1.62M$1.45M$665K$471K$551K$579K$750K
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$0$35.47M$27.03M$142.94M$67.1M$17.55M$54.3M$73.13M$75.9M$60K$60K$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$256K$256K$256K$256K$256K$318K$1.54M$208K$106K$3.44M$2.21M$85K$110K
Total Long-Term Assets$14.14M$51.96M$45.55M$163.18M$89.19M$19.99M$57.46M$74.78M$76.67M$3.97M$2.82M$664K$860K
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$364.39M$483.83M$452.39M$610.38M$643.07M$416.55M$435.2M$509M$329.36M$62.18M$56.28M$25.07M$3.91M
Liabilities
Current Liabilities
Accounts Payable$3.87M$4M$4.7M$2.78M$1.74M$4.22M$16.24M$5.44M$2.32M$2.28M$1.52M$415K$197K
Short-Term Debt$0$1.93M$0$0$0$0$1.38M$7.57M$6.88M$0$0$0$818K
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$139K$0$0
Current Unearned Revenue$0$0$0$0$0$0$0$8.7M$4.86M$3.43M$2.94M$10.09M$1.29M
Other Current Liabilities$11.09M$31.05M$23.77M$5.38M$4.18M$3.69M$2.15M$2.42M$1.59M$973K$772K$588K$485K
Total Current Liabilities$38.63M$45.43M$37.44M$26.05M$16.1M$19.82M$29.54M$21.84M$14.09M$5.71M$7.38M$11.68M$3.16M
Long-Term Liabilities
Long-Term Debt$12.03M$353.43M$0$0$0$0$0$625K$7.55M$13.81M$4.9M$4.79M$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$171K$140K$154K$115K$1.94M$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0-$171K-$140K-$154K-$115K$0$0
Other Long-Term Liabilities$276.53M$0$310.81M$304.41M$251.09M$0$0$171K$140K$3.4M$1.66M$569K$607K
Total Long-Term Liabilities$288.56M$367.54M$326.84M$322.23M$270.54M$0$654K$796K$7.69M$17.2M$6.57M$7.39M$607K
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$327.19M$412.97M$364.29M$348.28M$286.64M$19.82M$30.19M$22.63M$21.78M$22.91M$13.94M$19.07M$3.77M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$77.52M$77.52M$36.83M$34.67M
Common Stock$28K$30K$27K$29K$28K$27K$27K$27K$24K$3K$3K$17K$17K
Retained Earnings-$772.56M-$759.33M-$614.1M-$450.48M-$321.75M-$263.96M-$244.03M-$146.69M-$85.03M-$54.92M-$50.66M-$45.26M-$48.79M
Comprehensive Income & Other-$24K$305K-$797K-$5.25M-$422K-$4K$338K-$223K-$426K-$3.8M-$3.58M-$3.35M-$3.11M
Other Stockholders' Equity$809.74M$830.16M$702.17M$712.55M$678.15M$660.66M$649.01M$633.03M$392.59M$94.19M$93M$51.23M$48.92M
Total Equity$37.21M$70.87M$88.1M$262.1M$356.43M$396.73M$405.01M$486.37M$307.58M$39.27M$42.34M$5.99M$145K
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$364.39M$483.83M$452.39M$610.38M$643.07M$416.55M$435.2M$509M$329.36M$62.18M$56.28M$25.07M$3.91M
Supplementary Data
Total Debt$14.11M$369.46M$17.81M$19.45M$20.95M$342K$2.9M$8.26M$14.45M$13.81M$4.92M$4.92M$932K
Net Debt-$224.08M$246.38M-$18.15M-$51.86M-$474.77M-$250.11M-$168.12M-$105.34M-$66.74M-$37.42M-$46.76M-$17.27M-$1.88M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Operating Activities
Net Income$49.61M-$145.23M-$163.62M-$128.72M-$57.8M-$19.93M-$97.34M-$61.66M-$30.07M-$4.26M-$5.41M$3.53M-$5.54M
Depreciation & Amortization$2.42M$2.4M$2.38M$2.33M$2.09M$559K$514K$315K$183K$233K$274K$308K$580K
Deferred Income Tax$0$0$0$0$0$0$0-$1.23M$1.38M$757K$1.28M$62K-$621K
Stock-Based Compensation$36.07M$34.05M$33.2M$27.36M$15.35M$11.5M$12.41M$9.96M$4.38M$1.16M$604K$160K$151K
Changes in Working Capital:
  Accounts Receivable$6.92M-$33.91M-$5.43M-$543K-$876K$0$174K$1.43M$1.23M$1K$229K-$1.46M$268K
  Inventory$0$0$0$0$0$0$0$0-$237.97M-$5.34M$343K-$489K$132K
  Accounts Payable-$87.33M-$33.84M$10.94M$9.7M-$4.74M$0$0$7.08M$2.22M$1.25M$1.95M$482K-$255K
  Other Working Capital-$313K$1.43M-$5.83M-$2.32M-$1.87M-$6.77M$16.68M-$3.62M$238.61M-$2.94M-$9.05M$10.73M-$1.39M
Total Working Capital Change-$80.72M-$66.33M-$324K$6.84M-$7.49M-$6.77M$16.85M$3.46M$4.08M-$7.03M-$6.53M$9.27M-$1.25M
Other Non-Cash Items$12.31M$39.77M$7.56M$18.6M$1.93M$487K-$1.96M$646K$619K$105K$110K$1.27M$886K
Net Cash from Operating$19.7M-$135.34M-$120.8M-$73.59M-$45.92M-$14.16M-$69.52M-$48.51M-$19.44M-$9.03M-$9.67M$14.6M-$5.8M
Investing Activities
Capital Expenditures-$87K-$358K-$807K-$358K-$1.37M-$569K-$805K-$1.06M-$290K-$50K-$238K-$145K-$37K
Acquisitions$0$0$0$394.49M$0$0$0$347.54M$290.9M$0$0$0$0
Purchases of Investments-$196.41M-$380.38M-$303.92M-$802.5M-$118.66M-$194.93M-$251.81M-$347.54M-$290.9M$0$0$0$0
Sales of Investments$424.53M$476.13M$449.48M$408.02M$158.85M$289.97M$384.05M$206.15M$48.14M$0$0$0$0
Other Investing Activities$0$0$0-$394.49M$15K$0$0-$347.54M-$290.9M$0$0$5K$0
Net Cash from Investing$228.03M$95.4M$144.75M-$394.85M$38.84M$94.47M$131.43M-$142.45M-$243.06M-$50K-$238K-$140K-$37K
Financing Activities
Debt Repaid$76.8M-$34.77M$11.73M----$6.88M--$10M--$5M-
Common Stock Issuance$14.26M$100.84M$2.47M$11.83M$2.55M$496K$3.01M$227.48M$292.54M$31K$160K$0$4K
Common Stock Repurchases-$68.63M-$456K-$50M$0$0$0$0$0$0-$1K$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities-$1.45M-$8.1M-$43K$32.19M$249.75M$0$0$2.76M-$84K-$1.37M-$1.45M-$85K$0
Net Cash from Financing-$132.61M$127.05M-$59.3M$44.02M$252.3M-$879K-$4.49M$223.36M$292.45M$8.63M$39.4M$4.92M$1.96M
Forex Effect$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash$115.12M$87.11M-$35.34M-$424.42M$245.21M$79.44M$57.42M$32.41M$29.96M-$452K$29.5M$19.38M-$3.87M
Supplementary Data
Operating Cash Flow$19.7M-$135.34M-$120.8M-$73.59M-$45.92M-$14.16M-$69.52M-$48.51M-$19.44M-$9.03M-$9.67M$14.6M-$5.8M
Capital Expenditure-$87K-$358K-$807K-$358K-$1.37M-$569K-$805K-$1.06M-$290K-$50K-$238K-$145K-$37K
Free Cash Flow$19.61M-$135.69M-$121.61M-$73.95M-$47.29M-$14.73M-$70.32M-$49.57M-$19.73M-$9.08M-$9.91M$14.46M-$5.83M
Cash at Beginning$123.08M$35.97M$71.31M$495.73M$250.52M$171.02M$113.6M$81.25M$51.29M$51.68M$22.19M$2.81M$6.68M
Cash at End$238.2M$123.08M$35.97M$71.31M$495.73M$250.46M$171.02M$113.66M$81.25M$51.23M$51.68M$22.19M$2.81M